富血小板血浆分离应用于体外循环心脏手术的研究进展  

Progress in Platelet-Rich Plasmapheresis in Cardiopulmonary Bypass Cardiac Surgery

作　　者：翟晴 田阿勇[1] ZHAI Qing;TIAN Ayong(Department of Anesthesiology,The First Hospital,China Medical University,Shenyang 110001,China)

机构地区：[1]中国医科大学附属第一医院麻醉科,沈阳110001

出　　处：《中国医科大学学报》2019年第2期180-183,共4页Journal of China Medical University

基　　金：国家自然科学基金(81771342)

摘　　要：体外循环下的心脏手术术后易发生严重出血,往往需要血制品的输入,但是血制品资源有限,并且输注血制品成本较高,还伴随相应的不良反应。所以,近年来越来越多的研究应用富血小板血浆分离技术于此类手术,以达到减少体外循环对血液的破坏,实现血液保护的目的。Cardiac surgery with cardiopulmonary bypass is prone to severe bleeding and often requires blood product transfusion.However,blood products are limited,expensive,and can cause adverse reactions in recipients.Therefore,in recent years,increased research has been conducted on the use of platelet-rich plasmapheresis in such types of cardiac surgery,to reduce the destruction of the blood from cardiopulmonary bypass and to prevent blood loss.

关 键 词：富血小板血浆分离 体外循环 心脏手术 

分 类 号：R614.27[医药卫生—麻醉学]